A Mesh-Free Solution to Treat Pelvic Organ Prolapse

Did you know that approximately 300,000 women in the U.S. undergo surgical procedures for pelvic organ prolapse (POP) each year — and the prevalence increases with age? Many suffer in silence because of the perceived stigma associated with the condition, but treatment innovations are now available. ARMS Medical is providing innovative solutions for women’s pelvic health issues. Their pioneering technologies, including dCELL® Technology for pelvic floor surgery, may help women recover faster, and may lead to fewer complications, compared to older techniques.

Their innovative approach to pelvic floor surgery is based on the use of a next-generation tissue, DermaPure® and VNEW™, decellularized dermal allografts featuring patented dCELL® Technology which stimulate natural healing, minimize scarring, and are used to reinforce the repair of damaged tissue. DermaPure® and VNEW™ with dCELL® Technology have shown improved safety and efficacy in over 3,000 pelvic floor surgeries.